Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA grants breathrough therapy designation to Genzyme's Olipudase Alfa
FDA grants breathrough therapy designation to Genzyme's Olipudase Alfa
FDA grants breathrough therapy designation to Genzyme's Olipudase Alfa
Submitted by
admin
on June 4, 2015 - 11:51am
Source:
Yahoo/Reuters
News Tags:
Genzyme
FDA
olipudase alfa
Sanofi
Niemann-Pick disease
Headline:
FDA grants breathrough therapy designation to Genzyme's Olipudase Alfa
Do Not Allow Advertisers to Use My Personal information
